Global Market Study on Chondroitin Sulfate: Increasing Prevalence of Osteoarthritis Driving Growth

Chondroitin Sulfate  Market
  • Published On : Jan-2019 |
  • Pages : 285 Pages |
  • Format :

The chondroitin sulfate market report shows data for the estimated year (2018), and the forecasted year (2026), in terms of both, sales revenue (US$) and volume (MT). The report consists of forecast factors that affect and influence the chondroitin sulfate market, macroeconomic indicators, forecast factors, and the market outlook of the chondroitin sulfate market. The report also includes market dynamics such as restraints, drivers, opportunities, and trends in the chondroitin sulfate market. The drivers of the chondroitin sulfate market include increasing prevalence of osteoarthritis that is driving the increased demand for chondroitin sulfate for medicinal purposes, availability of chondroitin sulfate for multiple applications boosting its demand, burgeoning health-conscious population surging the demand for products incorporating chondroitin sulfate, and increasing clinical studies on chondroitin sulfate determining its superiority over existing products. The restraints in the global chondroitin sulfate market covered in the report are concerns regarding adulteration and poor quality of chondroitin sulfate that are hampering the growth of the market, and religious & cultural impediments about the usage of certain types of chondroitin sulfate (Middle Eastern Countries). The report also consists of the recent trends in the chondroitin sulfate market. We have included the global food and beverage sector outlook, global personal care industry outlook, global feed industry outlook, global pharmaceutical industry outlook, global osteoarthritis prevalence overview, and global nutraceuticals market overview.

We have also included a value chain analysis, strategic overview of the major key players in the global chondroitin sulfate market, and a detailed competition landscape analysis. This will give thorough information and overview of the chondroitin sulfate market to the users of the report. The chondroitin sulfate market report also provides market attractiveness analysis by source, form, end use, sales channel, and region. The chondroitin sulfate market report includes a detailed market structure, and it gives a comparison between the multinational players, regional players, and local players in the chondroitin sulfate market.

During the study of the chondroitin sulfate market, our analysts observed that, chondroitin sulfate was preferred by the elderly people suffering from different types of arthritis, which includes osteoarthritis, rheumatoid arthritis, osteomalacia, and others. The number of people suffering arthritis has increased significantly over the years, especially women. The consumption of chondroitin sulfate increases the functionality of the bone joints, reduces joint pain, and reduces inflammation in the joints. Thus, people suffering from arthritis are prescribed to consume chondroitin sulfate as a joint supplement. The report on the chondroitin sulfate market states that, the usage of chondroitin sulfate in pharmaceuticals and nutraceuticals is more when compared to other end uses, owing to the increasing consumption of supplements by consumers. By form, the powder form segment is expected to hold a significant market share when compared to the other segments in the global chondroitin sulfate market, due to variation in consumer preferences. By source, bovine segment is expected to hold a substantial market share in the global chondroitin sulfate market when compared to the other segments, owing to the high presence of bovines. By sales channel, the direct sales channel segment is expected to hold a prominent market share in the chondroitin sulfate market, owing to the increasing demand for chondroitin sulfate from supplement manufacturers. On the basis of region, North America holds a substantial market share in the global chondroitin sulfate market, owing to the increasing number of arthritis patients in the region. Followed by North America, Europe and APAC are estimated to hold high market shares in the global chondroitin sulfate market in terms of sales revenue over the coming years.

The report consists of the company profiles of the major manufacturers of chondroitin sulfate, and the revenue generated by these producers across five regions – Middle East and Africa (MEA), Asia Pacific (APAC), North America, Latin America, and Europe. In order to estimate the revenue of manufacturers, the average prices of chondroitin sulfate were obtained from various exporters, manufacturers, distributors, and suppliers of chondroitin sulfate through quotes. The key application segments of chondroitin sulfate were considered, and the vital ones were estimated by receiving feedback from various secondary sources and from many primary respondents. There were a few key data points that were collected and considered for the modelling approach, which include the overview of osteoarthritis patients, overview of the pharmaceutical industry, food and beverage outlook, overview of the nutraceuticals industry, and the average purchase price of chondroitin sulfate. The chondroitin sulfate market was estimated based on constant currency rates.

The report on chondroitin sulfate includes certain additional data for users, such as opportunity analysis of chondroitin sulfate, global economic outlook, production analysis of chondroitin sulfate by source, perceived benefits of chondroitin sulfate, recent developments in technology, marketing strategies adopted by the key players of chondroitin sulfate, key regulations regarding chondroitin sulfate, and forecast factors – relevance and impact.

Various primary and secondary sources were conducted during the course of the study. Secondary sources include recent publications, annual reports of major companies, Hoovers, and Factiva. The report also covers various market dynamics in the chondroitin sulfate market, such as trends, opportunities, restraints, and drivers. These dynamics affect the growth of the chondroitin sulfate market in multiple ways. The report also consists of detailed pricing analysis of chondroitin sulfate on the basis of source for every region, and global supply/demand analysis and trade scenario of chondroitin sulfate.

Detailed company profiling of key producers and manufacturers of chondroitin sulfate are included in the scope of the study. It helps evaluate their short-term and long term-strategies, and recent developments and various product offerings in the chondroitin sulfate market space. Some of the key players analyzed in the chondroitin sulfate market report are TSI Group Ltd., Solabia Group, AcerChem International Inc., Seikagaku Corporation, Jiaxing Hengjie Biopharmaceutical Co., Ltd, Aoxing Biotechnology Intl Co., Limited, Stanford Chemicals, Shanghai JBiChem International Trading Co., Ltd., Sioux Pharm, Inc., Pacific Rainbow International, Inc., Synutra, Inc., Zeria Pharmaceutical Co., Ltd., Summit Nutritionals International, Inc., Yantai Ruikangda Biochemical Products Co., Ltd., Bioibérica S.A., Dextra Laboratories Limited, CTPP-COPALIS, Derechos Reservados Syntex S.A., Hebei Sanxin Industry Group Co., Ltd., Sino Siam Biotechnique Co., Ltd., Iduron Ltd., Aroma NZ, Shandong Focuschem Biotech Co., Ltd., Kraeber and Co gmbh, Maypro Industries, Nuwen, Qingdao Green-extract Biology Science & Technology Co., Ltd., Qufu Guanglong Biological Products Factory, Shanghai Huiwen Biotech Corp., Ltd., United Fisheries limited, Yantai Dongcheng Biochemicals Co., Ltd., Shandong Yibao Biologics Co., Ltd, Cambridge Commodities Inc., Internacional Farmaceutica Argentina S.A., CAMB (Hong Kong) CO. Limited, Choncept, L.L.C., PureBulk, and Bayir Chemicals, among others.

Chondroitin sulfate is otherwise known as sulfated glycosaminoglycan (GAG). Chondroitin sulfate is composed of a huge chain of alternating sugars such as glucuronic acid and N-acetylgalactosamine. Chondroitin sulfate is a chemical compound that is present in the connective tissues in humans, which is found in the cartilages and joints of the body. Commercial chondroitin sulfate is manufactured from various animal sources such as porcine, bovine, poultry, fish, shark, crocodile, and other animals. Chondroitin sulfate is consumed as an alternative medicine to slow the progression of osteoarthritis. Chondroitin sulfate also helps reduce joint pain and inflammation. The regular consumption of chondroitin sulfate leads to improved joint functions. Commercial chondroitin sulfate is a mixture of glucosamine and chondroitin sulfate. Apart from improving the joint functions, chondroitin sulfate can also be used as an eye drop for sore eyes, besides having veterinary uses.

The different sources of chondroitin sulfate analyzed in the report are:

  • Bovine
  • Porcine
  • Poultry
  • Fish, Shark, & Crocodile
  • Others (Avian and Microbial Sources)

Various forms of chondroitin sulfate analyzed in the report are:

  • Powder
  • Tablets
  • Capsules

Various end uses of chondroitin sulfate analyzed in the report are:

  • Cosmetics & Personal Care
  • Pharmaceuticals & Nutraceuticals
  • Aquafeed
  • Pet Food & Veterinary Supplements

Various modes of sales channels analyzed in the report are:

  • Direct Sales
  • Indirect Sales
    • Drug Stores & Pharmacies
    • e-Commerce
    • Others

chondroitin sulfate market

Increasing Prevalence of Osteoarthritis Driving the Growing Demand for Chondroitin Sulfate for Medicinal Purposes

  • The major cause of disability among the ageing population is osteoarthritis. When compared to men, women are more likely to be affected by osteoarthritis, and the occurrence rate also increases with age.
    • According to CDC, National Arthritis Statistics of U.S., from the year 2013–2015, around 55.6 million U.S. adults (including both, men and women) were diagnosed with some form of arthritis, gout, lupus, rheumatoid arthritis, or fibromyalgia.
    • According to the Arthritis Research U.K., by 2035, around 8.3 million people in the country aged 45 years and above could have knee osteoarthritis.
    • According to AIHW, osteoarthritis affected more than 9% of the Australian population in 2014-15.
  • This rising prevalence is expected to increase the demand for chondroitin sulfate among supplement, pharmaceutical, and nutraceutical manufacturers.

Increasing Clinical Studies on Chondroitin Sulfate Determining its Superiority over Existing Products

  • The presence of different pharmaceutical products for disease treatment has created a competitive market scenario for chondroitin sulfate. Several clinical studies are going on for the identification of the effectiveness of chondroitin sulfate over existing products, as well as for different indications.
    • In June 2017, IBSA Institute Biochimique SA conducted a clinical trial using Chondroitin vs Celecoxib vs Placebo Trial. The institute named the trial as CONCEPT. This trial showed that, pharmaceutical-grade chondroitin sulfate was effective as an anti-inflammatory drug when compared to Placebo Trial and Celecoxib. The trial also revealed that, chondroitin sulfate is effective for reducing joint pain and increasing the functionality of the joints among knee osteoarthritis patients.

Burgeoning Health Conscious Population Surging the Demand for Products Incorporating Chondroitin Sulfate

  • The demand for chondroitin sulfate is expected to increase in the near future at a higher rate from dietary supplement manufacturers, owing to increasing healthcare expenditure, population ages, and higher emphasis of individuals on preventive care and self-management by means of dietary supplements in order to maintain health and wellness. Furthermore, the demand for chondroitin sulfate is increasing for joint health supplements with the burgeoning health conscious consumers and ageing population.

Increased Demand for Chondroitin Sulfate from the Booming Pet Food Industry

  • In the pet food industry, chondroitin sulfate is one of the established bioactive supplements that helps in supporting health benefit claims. Chondroitin sulfate is one of the key ingredients used in veterinary supplements and pet food products to avoid problems related to arthritis or hip dysplasia. Chondroitin sulfate also helps keep pets active and healthy with better joint mobility.
    • For instance, Zeria Group (ZPD) offers several strengths of chondroitin sulfate for the manufacturers of pet food in accordance with requirements, such as different grades containing 20%, 40%, and 80% chondroitin sulfate.

Cosmetic and Personal Care Industry Increasingly Using Chondroitin Sulfate in their Natural Products

  • The current trend in the cosmetic and personal care industry is to adopt the usage of chondroitin sulfate as a key ingredient in cosmetic products. It has been found that, chondroitin sulfate has various properties, such as its ability to moisturize, heal, and soothe the skin with its anti-inflammatory properties, and the ability to reinforce the intercellular matrix. Beauty product manufacturers are slowly adopting the usage of chondroitin sulfate in their hair care and skincare products.
    • In 2016, the company Zeria Group (ZPD) offered chondroitin sulfate under its brand name ScanDroitin, for the cosmetic industry.

Availability of Chondroitin Sulfate for Multiple Applications in Turn Boosting Demand

  • Usually, chondroitin sulfate is used in combination with various other ingredients such as N-acetyl glucosamine, manganese ascorbate, glucosamine hydrochloride, and glucosamine sulfate.
  • With the combination of glucosamine, chondroitin sulfate is used to treat osteoarthritis, the major functional segment. There are various other end uses for chondroitin sulfate, such as cosmetics, personal care, and veterinary supplements.
  • The increasing demand for chondroitin sulfate in multiple industries is projected to accelerate the growth of the chondroitin sulfate market in the coming years.

Company Profiles

  • TSI Group Ltd.,
  • Solabia Group
  • AcerChem International Inc.
  • Seikagaku Corporation
  • Jiaxing Hengjie Biopharmaceutical Co., Ltd
  • Aoxing Biotechnology Intl Co., Limited
  • Stanford Chemicals
  • Shanghai JBiChem International Trading Co.,Ltd.
  • Sioux Pharm, Inc.
  • Pacific Rainbow International, Inc.
  • Synutra, Inc
  • Zeria Pharmaceutical Co., Ltd.
  • Summit Nutritionals International, Inc.
  • Yantai Ruikangda Biochemical Products Co., Ltd.
  • Bioibérica S.A.
  • Dextra Laboratories Limited
  • Derechos Reservados Syntex S.A.
  • Hebei Sanxin Industry Group Co., Ltd.
  • Sino Siam Biotechnique Co., Ltd.
  • Iduron Ltd
  • Aroma NZ
  • Shandong Focuschem Biotech Co., Ltd.
  • Kraeber and Co gmbh
  • Maypro Industries
  • Nuwen
  • Qingdao Green-extract Biology Science & Technology Co.,Ltd
  • Qufu Guanglong Biological Products Factory
  • Shanghai Huiwen Biotech Corp.,Ltd
  • United Fisheries limited
  • Yantai Dongcheng Biochemicals Co., Ltd.
  • Shandong Yibao Biologics Co.,Ltd
  • Cambridge Commodities Inc.
  • Internacional Farmaceutica Argentina S.A.
  • CAMB (Hong Kong) CO. Limited
  • Choncept, L.L.C.
  • PureBulk
  • Bayir Chemicals
  • Shandong Runxin Biotechnology Co., Ltd.
  • Qingdao WanTuMing Biological Products Co., Ltd.
  • Others.
Back To Top